History | Setmelanotide for treating obesity caused by LEPR or POMC deficiency | Guidance | NICE

History

Documents created during the development process.

Final evaluation determination: 3764

Final evaluation determination: 3764
Final evaluation determination document (PDF 370 KB)

Published:

03 June 2022
Committee papers (PDF 512 KB)

Published:

03 June 2022

Evaluation consultation

Evaluation consultation
Evaluation consultation document (PDF 402 KB)

Published:

31 January 2022
Public committee slides (PDF 2.9 MB)

Published:

31 January 2022
Committee papers (PDF 3.47 MB)

Published:

31 January 2022
Evaluation consultation document (Online commenting)

Invitation to participate

Final scope (PDF 258 KB)

Published:

10 May 2021
Final stakeholder list (PDF 199 KB)

Published:

10 May 2021
Equality impact assessment (Scoping) (PDF 123 KB)

Published:

10 May 2021
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 147 KB)

Published:

10 May 2021

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 242 KB)

Published:

08 June 2020
Draft matrix pre referral (PDF 198 KB)

Published:

08 June 2020